Medical Care
Allergic Asthma Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 546883
- Pages: 130
- Figures: 209
- Views: 1
The global market for Allergic Asthma Therapeutics was estimated to be worth US$ 6655.8 million in 2023 and is forecast to a readjusted size of US$ 8092.3 million by 2030 with a CAGR of 2.8% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Allergic Asthma Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Allergic Asthma Therapeutics by region & country, by Type, and by Application.
The Allergic Asthma Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergic Asthma Therapeutics.
Market Segmentation
By Company
Aslan Pharmaceuticals Pte. Ltd.
Axikin Pharmaceuticals, Inc.
Baxalta Incorporated
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
CSL Limited
Fountain Biopharma Inc.
GlaxoSmithKline Plc
Hydra Biosciences, Inc.
Infinity Pharmaceuticals, Inc.
Kineta, Inc.
Mabtech Limited
Marinomed Biotechnologie GmbH
Mycenax Biotech Inc.
NeoPharm Co., Ltd.
Oxagen Limited
Panacea Biotec Limited
Segment by Type:
ASM-8
AXP-1275
Beta-escin
CHF-6001
CSL-311
Dalazatide
Others
Segment by Application
Clinic
Research Center
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Allergic Asthma Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Allergic Asthma Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Allergic Asthma Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Allergic Asthma Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Allergic Asthma Therapeutics by region & country, by Type, and by Application.
The Allergic Asthma Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergic Asthma Therapeutics.
Market Segmentation
By Company
Aslan Pharmaceuticals Pte. Ltd.
Axikin Pharmaceuticals, Inc.
Baxalta Incorporated
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
CSL Limited
Fountain Biopharma Inc.
GlaxoSmithKline Plc
Hydra Biosciences, Inc.
Infinity Pharmaceuticals, Inc.
Kineta, Inc.
Mabtech Limited
Marinomed Biotechnologie GmbH
Mycenax Biotech Inc.
NeoPharm Co., Ltd.
Oxagen Limited
Panacea Biotec Limited
Segment by Type:
ASM-8
AXP-1275
Beta-escin
CHF-6001
CSL-311
Dalazatide
Others
Segment by Application
Clinic
Research Center
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Allergic Asthma Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Allergic Asthma Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Allergic Asthma Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Allergic Asthma Therapeutics Product Introduction
1.2 Global Allergic Asthma Therapeutics Market Size Forecast
1.3 Allergic Asthma Therapeutics Market Trends & Drivers
1.3.1 Allergic Asthma Therapeutics Industry Trends
1.3.2 Allergic Asthma Therapeutics Market Drivers & Opportunity
1.3.3 Allergic Asthma Therapeutics Market Challenges
1.3.4 Allergic Asthma Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Allergic Asthma Therapeutics Players Revenue Ranking (2023)
2.2 Global Allergic Asthma Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Allergic Asthma Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Allergic Asthma Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Allergic Asthma Therapeutics
2.6 Allergic Asthma Therapeutics Market Competitive Analysis
2.6.1 Allergic Asthma Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Allergic Asthma Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergic Asthma Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 ASM-8
3.1.2 AXP-1275
3.1.3 Beta-escin
3.1.4 CHF-6001
3.1.5 CSL-311
3.1.6 Dalazatide
3.1.7 Others
3.2 Global Allergic Asthma Therapeutics Sales Value by Type
3.2.1 Global Allergic Asthma Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Allergic Asthma Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Allergic Asthma Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinic
4.1.2 Research Center
4.1.3 Hospital
4.1.4 Others
4.2 Global Allergic Asthma Therapeutics Sales Value by Application
4.2.1 Global Allergic Asthma Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Allergic Asthma Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Allergic Asthma Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Allergic Asthma Therapeutics Sales Value by Region
5.1.1 Global Allergic Asthma Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Allergic Asthma Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Allergic Asthma Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Allergic Asthma Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Allergic Asthma Therapeutics Sales Value, 2019-2030
5.2.2 North America Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Allergic Asthma Therapeutics Sales Value, 2019-2030
5.3.2 Europe Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Allergic Asthma Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Allergic Asthma Therapeutics Sales Value, 2019-2030
5.5.2 South America Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Allergic Asthma Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Allergic Asthma Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Allergic Asthma Therapeutics Sales Value
6.3 United States
6.3.1 United States Allergic Asthma Therapeutics Sales Value, 2019-2030
6.3.2 United States Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Allergic Asthma Therapeutics Sales Value, 2019-2030
6.4.2 Europe Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Allergic Asthma Therapeutics Sales Value, 2019-2030
6.5.2 China Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Allergic Asthma Therapeutics Sales Value, 2019-2030
6.6.2 Japan Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Allergic Asthma Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Allergic Asthma Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Allergic Asthma Therapeutics Sales Value, 2019-2030
6.9.2 India Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Aslan Pharmaceuticals Pte. Ltd.
7.1.1 Aslan Pharmaceuticals Pte. Ltd. Profile
7.1.2 Aslan Pharmaceuticals Pte. Ltd. Main Business
7.1.3 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Products, Services and Solutions
7.1.4 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Aslan Pharmaceuticals Pte. Ltd. Recent Developments
7.2 Axikin Pharmaceuticals, Inc.
7.2.1 Axikin Pharmaceuticals, Inc. Profile
7.2.2 Axikin Pharmaceuticals, Inc. Main Business
7.2.3 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
7.2.4 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 Axikin Pharmaceuticals, Inc. Recent Developments
7.3 Baxalta Incorporated
7.3.1 Baxalta Incorporated Profile
7.3.2 Baxalta Incorporated Main Business
7.3.3 Baxalta Incorporated Allergic Asthma Therapeutics Products, Services and Solutions
7.3.4 Baxalta Incorporated Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 Chiesi Farmaceutici SpA Recent Developments
7.4 Chiesi Farmaceutici SpA
7.4.1 Chiesi Farmaceutici SpA Profile
7.4.2 Chiesi Farmaceutici SpA Main Business
7.4.3 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Products, Services and Solutions
7.4.4 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 Chiesi Farmaceutici SpA Recent Developments
7.5 Circassia Pharmaceuticals Plc
7.5.1 Circassia Pharmaceuticals Plc Profile
7.5.2 Circassia Pharmaceuticals Plc Main Business
7.5.3 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Products, Services and Solutions
7.5.4 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 Circassia Pharmaceuticals Plc Recent Developments
7.6 CSL Limited
7.6.1 CSL Limited Profile
7.6.2 CSL Limited Main Business
7.6.3 CSL Limited Allergic Asthma Therapeutics Products, Services and Solutions
7.6.4 CSL Limited Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 CSL Limited Recent Developments
7.7 Fountain Biopharma Inc.
7.7.1 Fountain Biopharma Inc. Profile
7.7.2 Fountain Biopharma Inc. Main Business
7.7.3 Fountain Biopharma Inc. Allergic Asthma Therapeutics Products, Services and Solutions
7.7.4 Fountain Biopharma Inc. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Fountain Biopharma Inc. Recent Developments
7.8 GlaxoSmithKline Plc
7.8.1 GlaxoSmithKline Plc Profile
7.8.2 GlaxoSmithKline Plc Main Business
7.8.3 GlaxoSmithKline Plc Allergic Asthma Therapeutics Products, Services and Solutions
7.8.4 GlaxoSmithKline Plc Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 GlaxoSmithKline Plc Recent Developments
7.9 Hydra Biosciences, Inc.
7.9.1 Hydra Biosciences, Inc. Profile
7.9.2 Hydra Biosciences, Inc. Main Business
7.9.3 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
7.9.4 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 Hydra Biosciences, Inc. Recent Developments
7.10 Infinity Pharmaceuticals, Inc.
7.10.1 Infinity Pharmaceuticals, Inc. Profile
7.10.2 Infinity Pharmaceuticals, Inc. Main Business
7.10.3 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
7.10.4 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Infinity Pharmaceuticals, Inc. Recent Developments
7.11 Kineta, Inc.
7.11.1 Kineta, Inc. Profile
7.11.2 Kineta, Inc. Main Business
7.11.3 Kineta, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
7.11.4 Kineta, Inc. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 Kineta, Inc. Recent Developments
7.12 Mabtech Limited
7.12.1 Mabtech Limited Profile
7.12.2 Mabtech Limited Main Business
7.12.3 Mabtech Limited Allergic Asthma Therapeutics Products, Services and Solutions
7.12.4 Mabtech Limited Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.12.5 Mabtech Limited Recent Developments
7.13 Marinomed Biotechnologie GmbH
7.13.1 Marinomed Biotechnologie GmbH Profile
7.13.2 Marinomed Biotechnologie GmbH Main Business
7.13.3 Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Products, Services and Solutions
7.13.4 Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.13.5 Marinomed Biotechnologie GmbH Recent Developments
7.14 Mycenax Biotech Inc.
7.14.1 Mycenax Biotech Inc. Profile
7.14.2 Mycenax Biotech Inc. Main Business
7.14.3 Mycenax Biotech Inc. Allergic Asthma Therapeutics Products, Services and Solutions
7.14.4 Mycenax Biotech Inc. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.14.5 Mycenax Biotech Inc. Recent Developments
7.15 NeoPharm Co., Ltd.
7.15.1 NeoPharm Co., Ltd. Profile
7.15.2 NeoPharm Co., Ltd. Main Business
7.15.3 NeoPharm Co., Ltd. Allergic Asthma Therapeutics Products, Services and Solutions
7.15.4 NeoPharm Co., Ltd. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.15.5 NeoPharm Co., Ltd. Recent Developments
7.16 Oxagen Limited
7.16.1 Oxagen Limited Profile
7.16.2 Oxagen Limited Main Business
7.16.3 Oxagen Limited Allergic Asthma Therapeutics Products, Services and Solutions
7.16.4 Oxagen Limited Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.16.5 Oxagen Limited Recent Developments
7.17 Panacea Biotec Limited
7.17.1 Panacea Biotec Limited Profile
7.17.2 Panacea Biotec Limited Main Business
7.17.3 Panacea Biotec Limited Allergic Asthma Therapeutics Products, Services and Solutions
7.17.4 Panacea Biotec Limited Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.17.5 Panacea Biotec Limited Recent Developments
8 Industry Chain Analysis
8.1 Allergic Asthma Therapeutics Industrial Chain
8.2 Allergic Asthma Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Allergic Asthma Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Allergic Asthma Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Allergic Asthma Therapeutics Product Introduction
1.2 Global Allergic Asthma Therapeutics Market Size Forecast
1.3 Allergic Asthma Therapeutics Market Trends & Drivers
1.3.1 Allergic Asthma Therapeutics Industry Trends
1.3.2 Allergic Asthma Therapeutics Market Drivers & Opportunity
1.3.3 Allergic Asthma Therapeutics Market Challenges
1.3.4 Allergic Asthma Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Allergic Asthma Therapeutics Players Revenue Ranking (2023)
2.2 Global Allergic Asthma Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Allergic Asthma Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Allergic Asthma Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Allergic Asthma Therapeutics
2.6 Allergic Asthma Therapeutics Market Competitive Analysis
2.6.1 Allergic Asthma Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Allergic Asthma Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergic Asthma Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 ASM-8
3.1.2 AXP-1275
3.1.3 Beta-escin
3.1.4 CHF-6001
3.1.5 CSL-311
3.1.6 Dalazatide
3.1.7 Others
3.2 Global Allergic Asthma Therapeutics Sales Value by Type
3.2.1 Global Allergic Asthma Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Allergic Asthma Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Allergic Asthma Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinic
4.1.2 Research Center
4.1.3 Hospital
4.1.4 Others
4.2 Global Allergic Asthma Therapeutics Sales Value by Application
4.2.1 Global Allergic Asthma Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Allergic Asthma Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Allergic Asthma Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Allergic Asthma Therapeutics Sales Value by Region
5.1.1 Global Allergic Asthma Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Allergic Asthma Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Allergic Asthma Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Allergic Asthma Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Allergic Asthma Therapeutics Sales Value, 2019-2030
5.2.2 North America Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Allergic Asthma Therapeutics Sales Value, 2019-2030
5.3.2 Europe Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Allergic Asthma Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Allergic Asthma Therapeutics Sales Value, 2019-2030
5.5.2 South America Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Allergic Asthma Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Allergic Asthma Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Allergic Asthma Therapeutics Sales Value
6.3 United States
6.3.1 United States Allergic Asthma Therapeutics Sales Value, 2019-2030
6.3.2 United States Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Allergic Asthma Therapeutics Sales Value, 2019-2030
6.4.2 Europe Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Allergic Asthma Therapeutics Sales Value, 2019-2030
6.5.2 China Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Allergic Asthma Therapeutics Sales Value, 2019-2030
6.6.2 Japan Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Allergic Asthma Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Allergic Asthma Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Allergic Asthma Therapeutics Sales Value, 2019-2030
6.9.2 India Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Allergic Asthma Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Aslan Pharmaceuticals Pte. Ltd.
7.1.1 Aslan Pharmaceuticals Pte. Ltd. Profile
7.1.2 Aslan Pharmaceuticals Pte. Ltd. Main Business
7.1.3 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Products, Services and Solutions
7.1.4 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Aslan Pharmaceuticals Pte. Ltd. Recent Developments
7.2 Axikin Pharmaceuticals, Inc.
7.2.1 Axikin Pharmaceuticals, Inc. Profile
7.2.2 Axikin Pharmaceuticals, Inc. Main Business
7.2.3 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
7.2.4 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 Axikin Pharmaceuticals, Inc. Recent Developments
7.3 Baxalta Incorporated
7.3.1 Baxalta Incorporated Profile
7.3.2 Baxalta Incorporated Main Business
7.3.3 Baxalta Incorporated Allergic Asthma Therapeutics Products, Services and Solutions
7.3.4 Baxalta Incorporated Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 Chiesi Farmaceutici SpA Recent Developments
7.4 Chiesi Farmaceutici SpA
7.4.1 Chiesi Farmaceutici SpA Profile
7.4.2 Chiesi Farmaceutici SpA Main Business
7.4.3 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Products, Services and Solutions
7.4.4 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 Chiesi Farmaceutici SpA Recent Developments
7.5 Circassia Pharmaceuticals Plc
7.5.1 Circassia Pharmaceuticals Plc Profile
7.5.2 Circassia Pharmaceuticals Plc Main Business
7.5.3 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Products, Services and Solutions
7.5.4 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 Circassia Pharmaceuticals Plc Recent Developments
7.6 CSL Limited
7.6.1 CSL Limited Profile
7.6.2 CSL Limited Main Business
7.6.3 CSL Limited Allergic Asthma Therapeutics Products, Services and Solutions
7.6.4 CSL Limited Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 CSL Limited Recent Developments
7.7 Fountain Biopharma Inc.
7.7.1 Fountain Biopharma Inc. Profile
7.7.2 Fountain Biopharma Inc. Main Business
7.7.3 Fountain Biopharma Inc. Allergic Asthma Therapeutics Products, Services and Solutions
7.7.4 Fountain Biopharma Inc. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Fountain Biopharma Inc. Recent Developments
7.8 GlaxoSmithKline Plc
7.8.1 GlaxoSmithKline Plc Profile
7.8.2 GlaxoSmithKline Plc Main Business
7.8.3 GlaxoSmithKline Plc Allergic Asthma Therapeutics Products, Services and Solutions
7.8.4 GlaxoSmithKline Plc Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 GlaxoSmithKline Plc Recent Developments
7.9 Hydra Biosciences, Inc.
7.9.1 Hydra Biosciences, Inc. Profile
7.9.2 Hydra Biosciences, Inc. Main Business
7.9.3 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
7.9.4 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 Hydra Biosciences, Inc. Recent Developments
7.10 Infinity Pharmaceuticals, Inc.
7.10.1 Infinity Pharmaceuticals, Inc. Profile
7.10.2 Infinity Pharmaceuticals, Inc. Main Business
7.10.3 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
7.10.4 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Infinity Pharmaceuticals, Inc. Recent Developments
7.11 Kineta, Inc.
7.11.1 Kineta, Inc. Profile
7.11.2 Kineta, Inc. Main Business
7.11.3 Kineta, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
7.11.4 Kineta, Inc. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 Kineta, Inc. Recent Developments
7.12 Mabtech Limited
7.12.1 Mabtech Limited Profile
7.12.2 Mabtech Limited Main Business
7.12.3 Mabtech Limited Allergic Asthma Therapeutics Products, Services and Solutions
7.12.4 Mabtech Limited Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.12.5 Mabtech Limited Recent Developments
7.13 Marinomed Biotechnologie GmbH
7.13.1 Marinomed Biotechnologie GmbH Profile
7.13.2 Marinomed Biotechnologie GmbH Main Business
7.13.3 Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Products, Services and Solutions
7.13.4 Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.13.5 Marinomed Biotechnologie GmbH Recent Developments
7.14 Mycenax Biotech Inc.
7.14.1 Mycenax Biotech Inc. Profile
7.14.2 Mycenax Biotech Inc. Main Business
7.14.3 Mycenax Biotech Inc. Allergic Asthma Therapeutics Products, Services and Solutions
7.14.4 Mycenax Biotech Inc. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.14.5 Mycenax Biotech Inc. Recent Developments
7.15 NeoPharm Co., Ltd.
7.15.1 NeoPharm Co., Ltd. Profile
7.15.2 NeoPharm Co., Ltd. Main Business
7.15.3 NeoPharm Co., Ltd. Allergic Asthma Therapeutics Products, Services and Solutions
7.15.4 NeoPharm Co., Ltd. Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.15.5 NeoPharm Co., Ltd. Recent Developments
7.16 Oxagen Limited
7.16.1 Oxagen Limited Profile
7.16.2 Oxagen Limited Main Business
7.16.3 Oxagen Limited Allergic Asthma Therapeutics Products, Services and Solutions
7.16.4 Oxagen Limited Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.16.5 Oxagen Limited Recent Developments
7.17 Panacea Biotec Limited
7.17.1 Panacea Biotec Limited Profile
7.17.2 Panacea Biotec Limited Main Business
7.17.3 Panacea Biotec Limited Allergic Asthma Therapeutics Products, Services and Solutions
7.17.4 Panacea Biotec Limited Allergic Asthma Therapeutics Revenue (US$ Million) & (2019-2024)
7.17.5 Panacea Biotec Limited Recent Developments
8 Industry Chain Analysis
8.1 Allergic Asthma Therapeutics Industrial Chain
8.2 Allergic Asthma Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Allergic Asthma Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Allergic Asthma Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Allergic Asthma Therapeutics Market Trends
Table 2. Allergic Asthma Therapeutics Market Drivers & Opportunity
Table 3. Allergic Asthma Therapeutics Market Challenges
Table 4. Allergic Asthma Therapeutics Market Restraints
Table 5. Global Allergic Asthma Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Allergic Asthma Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Allergic Asthma Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Allergic Asthma Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Allergic Asthma Therapeutics
Table 10. Global Allergic Asthma Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergic Asthma Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Allergic Asthma Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Allergic Asthma Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Allergic Asthma Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Allergic Asthma Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Allergic Asthma Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Allergic Asthma Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Allergic Asthma Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Allergic Asthma Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Allergic Asthma Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Allergic Asthma Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Allergic Asthma Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Allergic Asthma Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Allergic Asthma Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Allergic Asthma Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Allergic Asthma Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Allergic Asthma Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Allergic Asthma Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Allergic Asthma Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Aslan Pharmaceuticals Pte. Ltd. Basic Information List
Table 32. Aslan Pharmaceuticals Pte. Ltd. Description and Business Overview
Table 33. Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Aslan Pharmaceuticals Pte. Ltd. (2019-2024)
Table 35. Aslan Pharmaceuticals Pte. Ltd. Recent Developments
Table 36. Axikin Pharmaceuticals, Inc. Basic Information List
Table 37. Axikin Pharmaceuticals, Inc. Description and Business Overview
Table 38. Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Axikin Pharmaceuticals, Inc. (2019-2024)
Table 40. Axikin Pharmaceuticals, Inc. Recent Developments
Table 41. Baxalta Incorporated Basic Information List
Table 42. Baxalta Incorporated Description and Business Overview
Table 43. Baxalta Incorporated Allergic Asthma Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Baxalta Incorporated (2019-2024)
Table 45. Baxalta Incorporated Recent Developments
Table 46. Chiesi Farmaceutici SpA Basic Information List
Table 47. Chiesi Farmaceutici SpA Description and Business Overview
Table 48. Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Chiesi Farmaceutici SpA (2019-2024)
Table 50. Chiesi Farmaceutici SpA Recent Developments
Table 51. Circassia Pharmaceuticals Plc Basic Information List
Table 52. Circassia Pharmaceuticals Plc Description and Business Overview
Table 53. Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Circassia Pharmaceuticals Plc (2019-2024)
Table 55. Circassia Pharmaceuticals Plc Recent Developments
Table 56. CSL Limited Basic Information List
Table 57. CSL Limited Description and Business Overview
Table 58. CSL Limited Allergic Asthma Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of CSL Limited (2019-2024)
Table 60. CSL Limited Recent Developments
Table 61. Fountain Biopharma Inc. Basic Information List
Table 62. Fountain Biopharma Inc. Description and Business Overview
Table 63. Fountain Biopharma Inc. Allergic Asthma Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Fountain Biopharma Inc. (2019-2024)
Table 65. Fountain Biopharma Inc. Recent Developments
Table 66. GlaxoSmithKline Plc Basic Information List
Table 67. GlaxoSmithKline Plc Description and Business Overview
Table 68. GlaxoSmithKline Plc Allergic Asthma Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of GlaxoSmithKline Plc (2019-2024)
Table 70. GlaxoSmithKline Plc Recent Developments
Table 71. Hydra Biosciences, Inc. Basic Information List
Table 72. Hydra Biosciences, Inc. Description and Business Overview
Table 73. Hydra Biosciences, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Hydra Biosciences, Inc. (2019-2024)
Table 75. Hydra Biosciences, Inc. Recent Developments
Table 76. Infinity Pharmaceuticals, Inc. Basic Information List
Table 77. Infinity Pharmaceuticals, Inc. Description and Business Overview
Table 78. Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Infinity Pharmaceuticals, Inc. (2019-2024)
Table 80. Infinity Pharmaceuticals, Inc. Recent Developments
Table 81. Kineta, Inc. Basic Information List
Table 82. Kineta, Inc. Description and Business Overview
Table 83. Kineta, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Kineta, Inc. (2019-2024)
Table 85. Kineta, Inc. Recent Developments
Table 86. Mabtech Limited Basic Information List
Table 87. Mabtech Limited Description and Business Overview
Table 88. Mabtech Limited Allergic Asthma Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Mabtech Limited (2019-2024)
Table 90. Mabtech Limited Recent Developments
Table 91. Marinomed Biotechnologie GmbH Basic Information List
Table 92. Marinomed Biotechnologie GmbH Description and Business Overview
Table 93. Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Marinomed Biotechnologie GmbH (2019-2024)
Table 95. Marinomed Biotechnologie GmbH Recent Developments
Table 96. Mycenax Biotech Inc. Basic Information List
Table 97. Mycenax Biotech Inc. Description and Business Overview
Table 98. Mycenax Biotech Inc. Allergic Asthma Therapeutics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Mycenax Biotech Inc. (2019-2024)
Table 100. Mycenax Biotech Inc. Recent Developments
Table 101. NeoPharm Co., Ltd. Basic Information List
Table 102. NeoPharm Co., Ltd. Description and Business Overview
Table 103. NeoPharm Co., Ltd. Allergic Asthma Therapeutics Products, Services and Solutions
Table 104. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of NeoPharm Co., Ltd. (2019-2024)
Table 105. NeoPharm Co., Ltd. Recent Developments
Table 106. Oxagen Limited Basic Information List
Table 107. Oxagen Limited Description and Business Overview
Table 108. Oxagen Limited Allergic Asthma Therapeutics Products, Services and Solutions
Table 109. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Oxagen Limited (2019-2024)
Table 110. Oxagen Limited Recent Developments
Table 111. Panacea Biotec Limited Basic Information List
Table 112. Panacea Biotec Limited Description and Business Overview
Table 113. Panacea Biotec Limited Allergic Asthma Therapeutics Products, Services and Solutions
Table 114. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Panacea Biotec Limited (2019-2024)
Table 115. Panacea Biotec Limited Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Allergic Asthma Therapeutics Downstream Customers
Table 119. Allergic Asthma Therapeutics Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Allergic Asthma Therapeutics Product Picture
Figure 2. Global Allergic Asthma Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Allergic Asthma Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Allergic Asthma Therapeutics Report Years Considered
Figure 5. Global Allergic Asthma Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Allergic Asthma Therapeutics Revenue in 2023
Figure 7. Allergic Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. ASM-8 Picture
Figure 9. AXP-1275 Picture
Figure 10. Beta-escin Picture
Figure 11. CHF-6001 Picture
Figure 12. CSL-311 Picture
Figure 13. Dalazatide Picture
Figure 14. Others Picture
Figure 15. Global Allergic Asthma Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Allergic Asthma Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 17. Product Picture of Clinic
Figure 18. Product Picture of Research Center
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Others
Figure 21. Global Allergic Asthma Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Allergic Asthma Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 23. North America Allergic Asthma Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 25. Europe Allergic Asthma Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 27. Asia Pacific Allergic Asthma Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia Pacific Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 29. South America Allergic Asthma Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 30. South America Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Allergic Asthma Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 33. Key Countries/Regions Allergic Asthma Therapeutics Sales Value (%), (2019-2030)
Figure 34. United States Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 35. United States Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 36. United States Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 37. Europe Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 38. Europe Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 39. Europe Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 40. China Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 41. China Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 42. China Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 43. Japan Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 44. Japan Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 45. Japan Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 46. South Korea Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 47. South Korea Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 48. South Korea Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 49. Southeast Asia Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 51. Southeast Asia Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 52. India Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 53. India Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 54. India Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 55. Allergic Asthma Therapeutics Industrial Chain
Figure 56. Allergic Asthma Therapeutics Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Table 1. Allergic Asthma Therapeutics Market Trends
Table 2. Allergic Asthma Therapeutics Market Drivers & Opportunity
Table 3. Allergic Asthma Therapeutics Market Challenges
Table 4. Allergic Asthma Therapeutics Market Restraints
Table 5. Global Allergic Asthma Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Allergic Asthma Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Allergic Asthma Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Allergic Asthma Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Allergic Asthma Therapeutics
Table 10. Global Allergic Asthma Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergic Asthma Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Allergic Asthma Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Allergic Asthma Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Allergic Asthma Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Allergic Asthma Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Allergic Asthma Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Allergic Asthma Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Allergic Asthma Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Allergic Asthma Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Allergic Asthma Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Allergic Asthma Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Allergic Asthma Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Allergic Asthma Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Allergic Asthma Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Allergic Asthma Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Allergic Asthma Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Allergic Asthma Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Allergic Asthma Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Allergic Asthma Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Aslan Pharmaceuticals Pte. Ltd. Basic Information List
Table 32. Aslan Pharmaceuticals Pte. Ltd. Description and Business Overview
Table 33. Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Aslan Pharmaceuticals Pte. Ltd. (2019-2024)
Table 35. Aslan Pharmaceuticals Pte. Ltd. Recent Developments
Table 36. Axikin Pharmaceuticals, Inc. Basic Information List
Table 37. Axikin Pharmaceuticals, Inc. Description and Business Overview
Table 38. Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Axikin Pharmaceuticals, Inc. (2019-2024)
Table 40. Axikin Pharmaceuticals, Inc. Recent Developments
Table 41. Baxalta Incorporated Basic Information List
Table 42. Baxalta Incorporated Description and Business Overview
Table 43. Baxalta Incorporated Allergic Asthma Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Baxalta Incorporated (2019-2024)
Table 45. Baxalta Incorporated Recent Developments
Table 46. Chiesi Farmaceutici SpA Basic Information List
Table 47. Chiesi Farmaceutici SpA Description and Business Overview
Table 48. Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Chiesi Farmaceutici SpA (2019-2024)
Table 50. Chiesi Farmaceutici SpA Recent Developments
Table 51. Circassia Pharmaceuticals Plc Basic Information List
Table 52. Circassia Pharmaceuticals Plc Description and Business Overview
Table 53. Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Circassia Pharmaceuticals Plc (2019-2024)
Table 55. Circassia Pharmaceuticals Plc Recent Developments
Table 56. CSL Limited Basic Information List
Table 57. CSL Limited Description and Business Overview
Table 58. CSL Limited Allergic Asthma Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of CSL Limited (2019-2024)
Table 60. CSL Limited Recent Developments
Table 61. Fountain Biopharma Inc. Basic Information List
Table 62. Fountain Biopharma Inc. Description and Business Overview
Table 63. Fountain Biopharma Inc. Allergic Asthma Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Fountain Biopharma Inc. (2019-2024)
Table 65. Fountain Biopharma Inc. Recent Developments
Table 66. GlaxoSmithKline Plc Basic Information List
Table 67. GlaxoSmithKline Plc Description and Business Overview
Table 68. GlaxoSmithKline Plc Allergic Asthma Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of GlaxoSmithKline Plc (2019-2024)
Table 70. GlaxoSmithKline Plc Recent Developments
Table 71. Hydra Biosciences, Inc. Basic Information List
Table 72. Hydra Biosciences, Inc. Description and Business Overview
Table 73. Hydra Biosciences, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Hydra Biosciences, Inc. (2019-2024)
Table 75. Hydra Biosciences, Inc. Recent Developments
Table 76. Infinity Pharmaceuticals, Inc. Basic Information List
Table 77. Infinity Pharmaceuticals, Inc. Description and Business Overview
Table 78. Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Infinity Pharmaceuticals, Inc. (2019-2024)
Table 80. Infinity Pharmaceuticals, Inc. Recent Developments
Table 81. Kineta, Inc. Basic Information List
Table 82. Kineta, Inc. Description and Business Overview
Table 83. Kineta, Inc. Allergic Asthma Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Kineta, Inc. (2019-2024)
Table 85. Kineta, Inc. Recent Developments
Table 86. Mabtech Limited Basic Information List
Table 87. Mabtech Limited Description and Business Overview
Table 88. Mabtech Limited Allergic Asthma Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Mabtech Limited (2019-2024)
Table 90. Mabtech Limited Recent Developments
Table 91. Marinomed Biotechnologie GmbH Basic Information List
Table 92. Marinomed Biotechnologie GmbH Description and Business Overview
Table 93. Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Marinomed Biotechnologie GmbH (2019-2024)
Table 95. Marinomed Biotechnologie GmbH Recent Developments
Table 96. Mycenax Biotech Inc. Basic Information List
Table 97. Mycenax Biotech Inc. Description and Business Overview
Table 98. Mycenax Biotech Inc. Allergic Asthma Therapeutics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Mycenax Biotech Inc. (2019-2024)
Table 100. Mycenax Biotech Inc. Recent Developments
Table 101. NeoPharm Co., Ltd. Basic Information List
Table 102. NeoPharm Co., Ltd. Description and Business Overview
Table 103. NeoPharm Co., Ltd. Allergic Asthma Therapeutics Products, Services and Solutions
Table 104. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of NeoPharm Co., Ltd. (2019-2024)
Table 105. NeoPharm Co., Ltd. Recent Developments
Table 106. Oxagen Limited Basic Information List
Table 107. Oxagen Limited Description and Business Overview
Table 108. Oxagen Limited Allergic Asthma Therapeutics Products, Services and Solutions
Table 109. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Oxagen Limited (2019-2024)
Table 110. Oxagen Limited Recent Developments
Table 111. Panacea Biotec Limited Basic Information List
Table 112. Panacea Biotec Limited Description and Business Overview
Table 113. Panacea Biotec Limited Allergic Asthma Therapeutics Products, Services and Solutions
Table 114. Revenue (US$ Million) in Allergic Asthma Therapeutics Business of Panacea Biotec Limited (2019-2024)
Table 115. Panacea Biotec Limited Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Allergic Asthma Therapeutics Downstream Customers
Table 119. Allergic Asthma Therapeutics Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Allergic Asthma Therapeutics Product Picture
Figure 2. Global Allergic Asthma Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Allergic Asthma Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Allergic Asthma Therapeutics Report Years Considered
Figure 5. Global Allergic Asthma Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Allergic Asthma Therapeutics Revenue in 2023
Figure 7. Allergic Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. ASM-8 Picture
Figure 9. AXP-1275 Picture
Figure 10. Beta-escin Picture
Figure 11. CHF-6001 Picture
Figure 12. CSL-311 Picture
Figure 13. Dalazatide Picture
Figure 14. Others Picture
Figure 15. Global Allergic Asthma Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Allergic Asthma Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 17. Product Picture of Clinic
Figure 18. Product Picture of Research Center
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Others
Figure 21. Global Allergic Asthma Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Allergic Asthma Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 23. North America Allergic Asthma Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 25. Europe Allergic Asthma Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 27. Asia Pacific Allergic Asthma Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia Pacific Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 29. South America Allergic Asthma Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 30. South America Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Allergic Asthma Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Allergic Asthma Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 33. Key Countries/Regions Allergic Asthma Therapeutics Sales Value (%), (2019-2030)
Figure 34. United States Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 35. United States Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 36. United States Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 37. Europe Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 38. Europe Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 39. Europe Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 40. China Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 41. China Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 42. China Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 43. Japan Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 44. Japan Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 45. Japan Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 46. South Korea Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 47. South Korea Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 48. South Korea Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 49. Southeast Asia Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 51. Southeast Asia Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 52. India Allergic Asthma Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 53. India Allergic Asthma Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 54. India Allergic Asthma Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 55. Allergic Asthma Therapeutics Industrial Chain
Figure 56. Allergic Asthma Therapeutics Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232